8 results match your criteria: "Department for Clinical Neurology[Affiliation]"
J Neurol
July 2004
University Clinic of Neurology, Clinical Department for Clinical Neurology, Waehringer Guertel 18-20, 1097, Vienna, Austria.
Background: Although transcatheter closure of patent foramen ovale (PFO) and atrial septal defect (ASD) has become a commonly performed intervention, the incidence of cerebral embolism with or without neurological deficits during such procedures has not been studied.
Methods: We monitored the middle cerebral artery in two different depths (48 mm and 53 mm) by continuous transcranial Doppler ultrasound during transcatheter PFO closure in 35 consecutive patients (F/M 20/15, mean age 47 +/- 11 years) and during ASD closure in 8 patients (F/M 7/1, mean age 45 +/- 5 years). All automatically detected high intensity transient signals (HITS) were manually reviewed to eliminate artifacts.
Acta Neurol Scand
July 2004
University Clinic of Neurology, Clinical Department for Clinical Neurology, University of Vienna Medical School, Waehringer Guertel, Vienna, Austria.
Objectives: In a series of 504 patients with multiple sclerosis (MS), quality of life (QOL) and its main clinical and demographic determinants were assessed in comparison with healthy individuals.
Materials And Methods: A postal questionnaire with self-completed measures of disability (Expanded Disability Status Scale, EDSS), QOL (Quality of Life Index, QLI), depressive mood (Self-rating Depression Scale, SDS), fatigue severity (Fatigue Severity Scale, FSS) and sleep quality (Pittsburgh Sleep Quality Index, PSQI) was sent to this sample of MS patients.
Results: Most patients were severely disabled; almost half were mildly to severely depressed, suffering from reduced sleep quality and/or fatigue.
J Neurol Sci
June 2004
Clinical Department for Clinical Neurology, University Clinic of Neurology, Vienna, Austria.
Objective: Treatment with statins reduces the risk of ischemic stroke among patients at increased risk for vascular disease. Recent experimental data suggest neuroprotective properties of statins in acute cerebral ischemia. We investigated whether a premedication with statins is associated with a better outcome in patients with acute ischemic cerebrovascular events.
View Article and Find Full Text PDFStroke
July 2004
Clinical Department for Clinical Neurology, Medical University of Vienna, Vienna, Austria.
Background And Purpose: Increased mean platelet volume (MPV), indicating higher platelet reactivity, is associated with an increased risk of myocardial infarction. Higher levels of MPV have been found in patients with acute ischemic stroke than in control subjects. Data from smaller studies regarding an association between MPV and stroke severity and outcome have been controversial.
View Article and Find Full Text PDFNeuroimage
January 2003
Department for Clinical Neurology, Währinger Gürtel 18-20, Vienna, Austria.
Using a whole-cortex magnetoencephalograph, magnetic field changes were recorded to describe brain activities related to simultaneous visual and olfactory processing and to detect odor-related influences on verbal information processing. Words had to be either shallowly (nonsemantic) or deeply (semantic) encoded by healthy young subjects, each of these tasks under two different kinds of olfactory stimulation. After each encoding phase, word recognition performance was tested.
View Article and Find Full Text PDFBrain Res Cogn Brain Res
November 2002
Department for Clinical Neurology, Währinger Gürtel 18-20, A-1090, Vienna, Austria.
The present study was meant to distinguish between unconscious and conscious olfactory information processing and to investigate the influence of olfaction on word information processing. Magnetic field changes were recorded in healthy young participants during deep encoding of visually presented words whereby some of the words were randomly associated with an odor. All recorded data were then split into two groups.
View Article and Find Full Text PDFStroke
December 2001
University Clinic of Neurology, Clinical Department for Clinical Neurology, Vienna, Austria.
Background And Purpose: Oral anticoagulation (OAC) and antiplatelet drugs are effective in the secondary prevention of ischemic cerebrovascular events. Only few data exist about the factors influencing the choice of a specific therapy for secondary prevention in patients with a recent stroke or transient ischemic attack (TIA).
Methods: Within a cross-sectional study, nested in a cohort we identified 931 patients with a recent ischemic stroke or TIA who were discharged with OAC or with one of the antiplatelet medications aspirin, clopidogrel, or the combination of aspirin and extended-release dipyridamole.
Neurology
December 1996
Department for Clinical Neurology, University of Innsbruck, Austria.
A large body of evidence indicates that the progression of Parkinson's disease (PD) may be fast in the preclinical stage as well as during the first years of the disease, with a subsequent slowing down of the disease process. As has been shown in the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study, the Unified Parkinson's Disease Rating Scale (UPDRS) motor examination scores declined at a rate of 8 to 9% per year in untreated patients. A subgroup of levodopa-naive DATATOP patients ("survivors") showed a much slower rate of progression, in the order of 3% per year, suggesting a more benign disease course.
View Article and Find Full Text PDF